Publication date: Available online 19 September 2026 Source: Cytotherapy Author(s): Natalia O. Ivanova, Anna I. Serdyuk, Ekaterina I. Fefelova, Arseniy E. Yuzhalin, Apollinariya V. Bogolyubova
Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926009734?dgcid=rss_sd_all
Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926009734?dgcid=rss_sd_all
“Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations.” Cytotherapy.
@article{article93662,
title = {Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926009734?dgcid=rss_sd_all}
}